Successful extracorporeal membrane oxygenation therapy in a child with coronavirus 2019 disease-associated ARDS and chemotherapy for Ewing's sarcoma.
Carmen Niño-TaravillaYuri Zuleta-MoralesHugo Otaola-ArcaBenigno MontenegroCristian Sotomayor FClaudia Greppi QPamela Silva GarayPaula Ortiz-FritzPublished in: Perfusion (2022)
Most children and adolescents with SARS-CoV-2 infection show no or mild symptoms, but those with medical histories can be susceptible to more severe forms of disease. There are few reported cases of extracorporeal membrane oxygenation (ECMO) in pediatric patients with coronavirus disease 2019 (COVID-19). We present a previously healthy 13-year-old male diagnosed with metastatic Ewing's sarcoma at the same time as catastrophic acute respiratory distress syndrome due to COVID-19, who was successfully supported by venovenous-ECMO while he received the corresponding chemotherapy protocol.ECMO can be used as salvage therapy in oncology pediatric patients with respiratory failure secondary to COVID-19. In addition, successful chemotherapy can be administered while patients are supported on ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- coronavirus disease
- acute respiratory distress syndrome
- respiratory failure
- mechanical ventilation
- respiratory syndrome coronavirus
- locally advanced
- end stage renal disease
- sars cov
- healthcare
- newly diagnosed
- squamous cell carcinoma
- ejection fraction
- randomized controlled trial
- palliative care
- radiation therapy
- chemotherapy induced
- small cell lung cancer
- prognostic factors
- depressive symptoms
- cell therapy
- sleep quality
- patient reported outcomes
- early onset
- young adults
- childhood cancer
- replacement therapy